Communiqué de presse

E-Scopics Receives FDA 510(k) Clearance for Hepatoscope-Derived Fat Fraction (HDFF) to Further Expand the Accessibility of Point-of-Care Non-Invasive Assessment of Fatty Liver
E-Scopics announces new FDA clearance for HepatoScope® with expanded capabilities in managing liver disease complications
Liver-Assessment Tool Hepatoscope® Cleared for Use in U.S. and Europe; Just as First Medication for MASH Gains FDA Approval.
E-Scopics announces commercial launch of Hepatoscope in the US and opens its subsidiary in the USA

Événements à venir

You will be redirected to the home page.